Tech Company Financing Transactions

RhinoCyte Funding Round

RhinoCyte, operating out of Louisville, raised $550 thousand from Kentucky Seed Capital Fund.

Transaction Overview

Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
$550,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 East Jefferson St. 135
Louisville, KY 40202
USA
Email Address
Overview
RhinoCyte Inc. is a biopharmaceutical company focused on developing innovative treatments using stem cells taken from the nose lining of adults. The company's goal is to extend and enhance patients' quality of life through regenerative medicine treatments.
Profile
RhinoCyte LinkedIn Company Profile
Social Media
RhinoCyte Company Twitter Account
Company News
RhinoCyte News
Facebook
RhinoCyte on Facebook
YouTube
RhinoCyte on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Fred Roisen
  Fred Roisen LinkedIn Profile  Fred Roisen Twitter Account  Fred Roisen News  Fred Roisen on Facebook
Co-Founder
Steve Gailar
  Steve Gailar LinkedIn Profile  Steve Gailar Twitter Account  Steve Gailar News  Steve Gailar on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2014: Synup venture capital transaction
Next: 9/30/2014: Five Star Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary